Investors The leading provider of patient engagement tools to support efficient clinical trials

Founded in 2010, AiCure is a global technology company that delivers novel, comprehensive understanding of patients using machine learning and computer vision.

AiCure's software helps clinical trial participants with trial protocols and medication adherence while giving drug sponsors and clinical trial sites deeper understanding of treatment effects​.

AiCure Highlights At-A-Glance

  • Only AI software platform of its kind, purposely built to utilize advanced computer vision to enhance clinical trial effectiveness

  • Unrivaled IP comprising a massive data lake, trained algorithms, leading predictive analytics capabilities and over 84 patents

  • Addressing a $3.5B market with an expanding set of use cases across clinical drug development and commercial pharma

  • Uniquely well positioned for expansion across decentralized clinical trials, additional therapeutic areas, and extend into commercial and population health

  • Led by an experienced and ambitious team of experts in pharma, life sciences, machine learning and technology

Growing Footprint in Clinical Trials

AiCure has supported trials across 15+ therapeutic areas:

  • CNS/Neurology/Neurodegeneration

  • Allergies/Immunology

  • Population Health

  • Women’s Health

  • Psychiatry

  • Respiratory

  • Oncology

  • Infectious Disease

  • Endocrinology

  • Cardiovascular

  • Dermatology

  • Gastrointestinal

  • Pediatrics

  • Ophthalmology

  • Pain

Robust Patent Portfolio

AiCure has 84 Awarded Patents

30 Patents Pending around the world

8 Registered Trademarks

Regulatory Compliance & Certifications